According to a study conducted on 800 individuals with T2DM in 2018, rs77474263 and rs77630697 genetic variants of the SLC47A1 gene were found to be an essential determinant in metformin therapy response in Pakistani patients. Here, SLC47A1 is linked to type 2 diabetes mellitus.